Iterum Therapeutics Plc (NASDAQ:ITRM) Stock Falls Ahead of Quarterly Earnings

November 8, 2021

Clinical stage pharmaceutical firm Iterum Therapeutics Plc (NASDAQ:ITRM) did not have a particularly great time in the capital markets this past Friday and its stock ended the day with a decline of as much as 4%. Trading Data On Friday, ITRM stock fell 4% at $0.5640 with more than 3.57 million million shares, compared to its average volume of 5.43 million shares. The stock has moved within a range of…

Read More >>